These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 31378395)

  • 1. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Chappell LC; Bell JL; Smith A; Linsell L; Juszczak E; Dixon PH; Chambers J; Hunter R; Dorling J; Williamson C; Thornton JG;
    Lancet; 2019 Sep; 394(10201):849-860. PubMed ID: 31378395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
    Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial.
    Chappell LC; Gurung V; Seed PT; Chambers J; Williamson C; Thornton JG;
    BMJ; 2012 Jun; 344():e3799. PubMed ID: 22695903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Ovadia C; Seed PT; Sklavounos A; Geenes V; Di Ilio C; Chambers J; Kohari K; Bacq Y; Bozkurt N; Brun-Furrer R; Bull L; Estiú MC; Grymowicz M; Gunaydin B; Hague WM; Haslinger C; Hu Y; Kawakita T; Kebapcilar AG; Kebapcilar L; Kondrackienė J; Koster MPH; Kowalska-Kańka A; Kupčinskas L; Lee RH; Locatelli A; Macias RIR; Marschall HU; Oudijk MA; Raz Y; Rimon E; Shan D; Shao Y; Tribe R; Tripodi V; Yayla Abide C; Yenidede I; Thornton JG; Chappell LC; Williamson C
    Lancet; 2019 Mar; 393(10174):899-909. PubMed ID: 30773280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis.
    Ovadia C; Sajous J; Seed PT; Patel K; Williamson NJ; Attilakos G; Azzaroli F; Bacq Y; Batsry L; Broom K; Brun-Furrer R; Bull L; Chambers J; Cui Y; Ding M; Dixon PH; Estiú MC; Gardiner FW; Geenes V; Grymowicz M; Günaydin B; Hague WM; Haslinger C; Hu Y; Indraccolo U; Juusela A; Kane SC; Kebapcilar A; Kebapcilar L; Kohari K; Kondrackienė J; Koster MPH; Lee RH; Liu X; Locatelli A; Macias RIR; Madazli R; Majewska A; Maksym K; Marathe JA; Morton A; Oudijk MA; Öztekin D; Peek MJ; Shennan AH; Tribe RM; Tripodi V; Türk Özterlemez N; Vasavan T; Wong LFA; Yinon Y; Zhang Q; Zloto K; Marschall HU; Thornton J; Chappell LC; Williamson C
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):547-558. PubMed ID: 33915090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis.
    Roncaglia N; Locatelli A; Arreghini A; Assi F; Cameroni I; Pezzullo JC; Ghidini A
    BJOG; 2004 Jan; 111(1):17-21. PubMed ID: 14687046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.
    Kawakita T; Parikh LI; Ramsey PS; Huang CC; Zeymo A; Fernandez M; Smith S; Iqbal SN
    Am J Obstet Gynecol; 2015 Oct; 213(4):570.e1-8. PubMed ID: 26071912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial.
    Fleminger J; Seed PT; Smith A; Juszczak E; Dixon PH; Chambers J; Dorling J; Williamson C; Thornton JG; Chappell LC
    BJOG; 2021 May; 128(6):1066-1075. PubMed ID: 33063439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T; Timonen S; Linden M; Suvitie P; Ekblad U
    BMC Gastroenterol; 2015 Jul; 15():92. PubMed ID: 26215400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M; Czajkowski K; Smolarczyk R
    Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo.
    Palma J; Reyes H; Ribalta J; Hernández I; Sandoval L; Almuna R; Liepins J; Lira F; Sedano M; Silva O; Tohá D; Silva JJ
    J Hepatol; 1997 Dec; 27(6):1022-8. PubMed ID: 9453428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Chappell LC; Brocklehurst P; Green ME; Hunter R; Hardy P; Juszczak E; Linsell L; Chiocchia V; Greenland M; Placzek A; Townend J; Marlow N; Sandall J; Shennan A;
    Lancet; 2019 Sep; 394(10204):1181-1190. PubMed ID: 31472930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A; Marschall HU; Lammert F; Mattsson LA
    Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011.
    ; Lee RH; Mara Greenberg ; Metz TD; Pettker CM
    Am J Obstet Gynecol; 2021 Feb; 224(2):B2-B9. PubMed ID: 33197417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X; Kong Y; Zhang F; Wang T; Yan J
    Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
    J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gradual dosing of ursodeoxycholic acid in mothers with intrahepatic cholestasis of pregnancy may improve composite neonatal outcome.
    Hamud A; Cohen MJ; Hochner-Celnikier D; Bar-Oz B; Ackerman Z
    Ann Hepatol; 2024; 29(3):101490. PubMed ID: 38403070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
    Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
    Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrahepatic cholestasis in pregnancy treated with ursodeoxycholic acid].
    Grønlund LA
    Ugeskr Laeger; 1999 Sep; 161(39):5433-4. PubMed ID: 10553357
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.